SGLT2 inhibitors and geriatric syndromes in older adults with type 2 diabetes: A real-world cohort study
{{output}}
Background: Sodium-glucose cotransporter-2 (SGLT2) inhibitors provide cardiorenal benefits in type 2 diabetes mellitus (T2DM), but concerns persist regarding potential exacerbation of geriatric syndromes through osmotic diuresis,... ...